Evidence map›Paper›PMID 20599778›Full record

ArticleBiochemical pharmacology2010

Identification and characterization of a novel estrogenic ligand actinopolymorphol A.

Emily Powell, Sheng-Xiong Huang, Yong Xu, Scott R Rajski, Yidan Wang, Noel Peters, Song Guo, H Eric Xu, F Michael Hoffmann, Ben Shen and 1 more

Abstract read
In one paragraph

Article in Biochemical pharmacology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Differential action of monohydroxylated polycyclic aromatic hydrocarbons with estrogen receptors α and β.Toxicological sciences : an official journal of the Society of Toxicology · 2013
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Emily PowellMcArdle Laboratory for Cancer Research, University of Wisconsin-Madison, Madison, WI 53706, USA.
Sheng-Xiong Huang
Yong Xu
Scott R Rajski
Yidan Wang
Noel Peters
Song Guo
H Eric Xu
F Michael Hoffmann
Ben Shen
Wei Xu

Funding

Training in Cancer Biology Training GrantT32CA009135 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI SUGDEN, WILLIAM M. · 1985 to 2024
$10.4M
Zeeh Pharmaceutical Experimental StationU19CA113297 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI THORSON, JON SCOTT · 2005 to 2009
$5.4M
Transcriptional Regulation of Estrogen Receptor (ER) by CARM1R01CA125387 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI XU, WEI · 2008 to 2012
$1.6M
Identification of ERalpha/ERbeta Heterodimer-specific Ligands by HTSR03MH089442 · NIMH · UNIVERSITY OF WISCONSIN-MADISON · PI XU, WEI · 2009 to 2010
$74k
NCI NIH HHS CA113297NCI NIH HHS R01 CA125387NCI NIH HHS R01CA125387NCI NIH HHS T32 CA009135NCI NIH HHS U19 CA113297NIMH NIH HHS R03 MH089442NIMH NIH HHS R03MH089442
6 · The paper itself

Abstract

Xenoestrogenic compounds are abundant in the modern environment including phytoestrogens from plants, chemical by-products from industry, and secondary metabolites from microbes; all can profoundly affect human health. Consequently mechanism-based screens are urgently needed to improve the rate at which the xenoestrogens are discovered. Estrogen Receptor (ER) dimerization is required for target gene transcription. The three ER dimer pairs (ERalpha/alpha homodimers, ERbeta/beta homodimers, and ERalpha/beta heterodimers) exhibit diverse physiological responses in response to ligand-dependent activation with ERalpha/alpha homodimers being pro-proliferative and ERbeta/beta homodimers being anti-proliferative. The biological role of the ERalpha/beta heterodimer remains unclear. We previously developed a cell-based, bioluminescence resonance energy transfer (BRET) assay that can distinguish natural estrogenic compounds based on their abilities to activate the three diverse ER dimer pairs. Using BRET assays, we sought to identify novel xenoestrogens from soil bacteria that preferentially activate ERalpha/beta heterodimer with hopes of shedding light on the biological function of this elusive dimer pair. Here we describe the application of BRET assays in high throughput screens of crude bacterial extracts not previously screened for ER modulatory function and originating from unique ecological niches. Here we report the discovery and biological evaluation of a new natural product, actinopolymorphol A (1), that preferentially induces ERalpha/beta dimerization. Actinopolymorphol A represents the first representative of a new ER modulatory scaffold.

Indexed as

AcetatesAnimalsBacteriaBiological AssayBreast NeoplasmsCell Line, TumorDose-Response Relationship, DrugEstrogensFemaleHumansModels, MolecularMolecular StructurePhenolsProtein BindingProtein ConformationRatsAcetatesactinopolymorphol AEstrogensPhenolsReceptors, Estrogen

Identifiers

PMID20599778
PMCPMC2934894

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.